enGene Holdings Inc
NASDAQ:ENGN
Balance Sheet
Balance Sheet Decomposition
enGene Holdings Inc
enGene Holdings Inc
Balance Sheet
enGene Holdings Inc
| Oct-2023 | Oct-2024 | Oct-2025 | ||
|---|---|---|---|---|
| Assets | ||||
| Cash & Cash Equivalents |
82
|
173
|
50
|
|
| Cash Equivalents |
82
|
173
|
50
|
|
| Short-Term Investments |
0
|
65
|
144
|
|
| Total Receivables |
2
|
0
|
1
|
|
| Other Current Assets |
2
|
9
|
7
|
|
| Total Current Assets |
85
|
247
|
201
|
|
| PP&E Net |
1
|
3
|
10
|
|
| PP&E Gross |
1
|
3
|
10
|
|
| Accumulated Depreciation |
2
|
2
|
2
|
|
| Long-Term Investments |
0
|
60
|
9
|
|
| Other Long-Term Assets |
1
|
1
|
1
|
|
| Total Assets |
87
N/A
|
311
+258%
|
221
-29%
|
|
| Liabilities | ||||
| Accounts Payable |
1
|
1
|
7
|
|
| Accrued Liabilities |
3
|
12
|
17
|
|
| Short-Term Debt |
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
1
|
8
|
|
| Other Current Liabilities |
0
|
0
|
1
|
|
| Total Current Liabilities |
5
|
15
|
32
|
|
| Long-Term Debt |
9
|
22
|
15
|
|
| Other Liabilities |
0
|
1
|
6
|
|
| Total Liabilities |
14
N/A
|
39
+166%
|
54
+39%
|
|
| Equity | ||||
| Common Stock |
259
|
510
|
513
|
|
| Retained Earnings |
200
|
255
|
372
|
|
| Additional Paid In Capital |
14
|
19
|
27
|
|
| Other Equity |
1
|
1
|
1
|
|
| Total Equity |
72
N/A
|
273
+276%
|
168
-38%
|
|
| Total Liabilities & Equity |
87
N/A
|
311
+258%
|
221
-29%
|
|
| Shares Outstanding | ||||
| Common Shares Outstanding |
23
|
51
|
52
|
|